Connection

Eric Bartee to Immunotherapy

Back to Details
This is a "connection" page, showing publications Eric Bartee has written about Immunotherapy.
Eric Bartee
Connection Strength
0.854
Immunotherapy
  1. Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy. J Immunother Cancer. 2019 01 16; 7(1):11.
    View in: PubMed
    Score: 0.587
  2. The use of oncolytic virotherapy in the neoadjuvant setting. J Immunother Cancer. 2022 04; 10(4).
    View in: PubMed
    Score: 0.183
  3. Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using PET/MRI in a Mouse Model of Disseminated Ovarian Cancer. Int J Mol Sci. 2022 Sep 10; 23(18).
    View in: PubMed
    Score: 0.047
  4. Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.